human noroviru honor major caps nonbacteri gastroenter worldwide yet despite impact society vaccine antivirus current lack replica system wide apply value antivirus compound thu accuser process drug discovery infect rupintrivir irrevers inhibitor rhinoviru c proteam report inhibit replica normal virus via inhibit report first time genre rupintrivirresist cell vitro sequence analysis reveal contain amino acid substitute alain valign av isoleucin iv viral n applied cells flores reason energy transfer fret assay active demons involve enhance resist furthermore valid effect mutant use revert gene marin mn demons recombin strain single substitute also show reduce suspect summary combine differ approach correct conduit lead resist mutant rapidly occur 